Le Lézard
Classified in: Health
Subjects: PER, TRI

Quorum Review IRB and Kinetiq Leadership Participate in Multiple Clinical Research Initiatives


SEATTLE, May 8, 2018 /PRNewswire/ -- Leadership from Quorum Review IRB and Kinetiq, the consulting and technology division of Quorum, have been invited, elected, or appointed to several key positions with clinical research initiatives, national trade organizations, and in respected academia. This level of involvement demonstrates the organization's mission to build a community dedicated to the well-being of all people and move research forward together.

Quorum Review IRB is the first name in streamlined, service-centered independent ethics and regulatory review. Quorum assures the ethical integrity of clinical research. We help our partners advance the frontiers of medical innovation with greater confidence and control while sustaining the rights, dignity and safety of participants. Beyond traditional institutional review board services, Quorum offerings include single IRB (sIRB) services for institutions and IRB-integrated eConsent. (PRNewsfoto/Quorum Review IRB)

"We are proud and excited to be involved with these reputable organizations that positively impact the clinical research community," says Quorum CEO Cami Gearhart. "The pursuit of our mission supports these efforts and we appreciate that we are recognized as clinical research thought leaders."

Cami Gearhart leads by example as the current president of the Northwest Association for Biomedical Research (NWABR), which is an organization that helps foster understanding for biomedical research and ethical conduct.

Dr. Stephen Rosenfeld, Quorum executive IRB chair, serves as the chair of the Secretary's Advisory Committee on Human Research Protections (SACHRP) for the U.S. Department of Health and Human Services. He also was recently appointed to the board of Public Responsibility in Medicine and Research (PRIM&R).

James Riddle, vice president of client services for Kinetiq, was appointed to the steering committee of Clinical Trials Transformation Initiative (CTTI). In addition, James was selected as a domain chair of the Alliance for Clinical Research Excellence and Safety (ACRES) Site Accreditation and Safety Initiative (SASI). He also sits on the editorial board for IRB Advisor, a newsletter for institutional review board management.

Mitchell Parrish, vice president of legal affairs for Kinetiq, was recently elected to the board for Life Science Washington (LSW). This is in addition to his work as co-chair of the annual IRB Conference hosted by NWABR and as a faculty member of the Regulatory Affairs Professionals Society (RAPS). He also sits on the steering committee for Harvard's Multi-Regional Clinical Trials (MRCT) Center and is a Global Impact Partner representative for the Society for Clinical Research Sites (SCRS).

About Quorum Review IRB
Visit our website.

About Kinetiq
Visit our website.

Contact:

Scott Smith
Director of Marketing
(206) 448-4082
[email protected]

 

Kinetiq is a consulting and technology division of Quorum that delivers innovative solutions to the challenges of human subject protections and compliance in clinical research. Kinetiq works with clinical researchers, research institutions, pharmaceutical, biotechnology, and medical device companies?as well as others around the world?to develop contemporary approaches to a changing landscape. (PRNewsfoto/Quorum Review IRB)

SOURCE Quorum Review IRB


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
Closed System Transfer Devices Market in terms of revenue was estimated to be worth $1.1 billion in 2024 and is poised to reach $2.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...



News published on and distributed by: